Clinical trial
Economic Impact of Guidelines for Gastroesophageal Reflux Disease
NCT00057174 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00057174 |
|---|---|
| Title | Economic Impact of Guidelines for Gastroesophageal Reflux Disease |
| Official title | Economic Impact of Guidelines for Gastroesophageal Reflux Disease |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Collaborators | Oregon Health and Science University |
| Status | Completed |
| Study type | Interventional |
| Conditions | Gastroesophageal Reflux Disease, Health Economics |
| Intervention type | Drug |
| Interventions | Disease management of gastroesophageal reflux disease |
| Enrollment | 484 |
| Completion | Jun 1, 2004 |
| First posted | Mar 28, 2003 |
| Last update posted | Apr 7, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: